Arkolith/Insider Trading/ODTX/Form 4

Leiden Jeffrey M

DirectorOdyssey Therapeutics, Inc. (ODTX) · full profile →Form 4 · filed May 11, 2026
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
9
4 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2026Conversion(C)29K——29K
May 11, 2026Option exercise(M)3K——32K
May 11, 2026Tax withholding(F)17$18.00$30632K
May 8, 2026Buy(P)5K$20.00$100K270K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 11, 2026Option exercise(M)29K——0
May 11, 2026Conversion(C)79K——0
May 11, 2026Conversion(C)100K——0
May 11, 2026Conversion(C)96K——0
May 7, 2026Grant(A)626K—$0626K

Transaction Codes

C
Conversion of a derivative
M
Option exercise / conversion
F
Shares withheld for taxes
P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-217607) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML